JAMA Oncology Author Interviews Podcast Por JAMA Network arte de portada

JAMA Oncology Author Interviews

JAMA Oncology Author Interviews

De: JAMA Network
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

    Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
    Sep 18 2025

    Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
    Más Menos
    13 m
  • Proportional Sedation for Persistent Agitated Delirium in Palliative Care

    Proportional Sedation for Persistent Agitated Delirium in Palliative Care
    Jul 31 2025

    Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Proportional Sedation for Persistent Agitated Delirium in Palliative Care
    Más Menos
    18 m
  • New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

    New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
    May 29 2025

    Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD.

    Related Content:

    • New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
    Más Menos
    19 m
Todavía no hay opiniones